Advertisement

Bayer shareholders vote against board over Monsanto deal
bayer

Bayer shareholders vote against board over Monsanto deal

Bayer chief executive Werner Baumann was dealt a blow on Friday at the German chemical giant's annual general meeting, amid tensions over last year's decision to buy US seeds and pesticides maker Monsanto, as disgruntled shareholders voted against management.
Bayer stock plummets after Monsanto ruling
bayer

Bayer stock plummets after Monsanto ruling

Germany’s biggest pharmaceuticals company has taken an enormous hit on the stock market after a court in the US ordered subsidiary company Monsanto to pay $290 million worth of damages to a terminally ill groundskeeper in California.
German chemical giant in talks to buy Monsanto
Farming

German chemical giant in talks to buy Monsanto

German pharmaceuticals giant Bayer and the US group Monsanto said Thursday they are in talks on a possible merger to create a global player in pesticides, seeds and genetically modified crops, following weeks of speculation about a possible tie-up.
Pharma giant Bayer in contempt: US
Health

Pharma giant Bayer in contempt: US

The United States government accused German pharmaceutical giant Bayer of making scientifically unproven statements about the health benefits of a popular probiotic on Friday.
Bayer fights for cancer drug patent in India
Health

Bayer fights for cancer drug patent in India

German pharmaceuticals giant Bayer, maker of Aspirin, vowed Monday to fight a ruling by the patent authorities in India allowing a local company to produce and sell a generic copy of its anti-cancer drug Nexavar.
Bayer loses patent in India test case
india

Bayer loses patent in India test case

Germany’s pharmaceutical giant Bayer has made history by being the first firm ordered to give up control of a patented drug after an Indian court said its cancer drug Nexavar was too expensive.
US allows suit against drug-maker Bayer to go forward
US

US allows suit against drug-maker Bayer to go forward

The US Supreme Court has allowed the continuation of a class-action suit by alleged victims of the anti-cholesterol drug Baycol (known as Lipobay outside the US), which was taken off the market worldwide in 2001 by German pharmaceuticals giant Bayer.
Bayer raises outlook on strong results
bayer

Bayer raises outlook on strong results

German chemical and pharmaceutical group Bayer posted an 8.4-percent increase in first-quarter net profit on Thursday while signalling improvement in its agricultural products division.